Paralysis News and Research

RSS

Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.

Winners of the first CERF Medical Engineering Prize for ALS Research announced

The Cullen Education and Research Fund announced the recipients of the first CERF Medical Engineering Prize for ALS Research: Dr. Leigh Hochberg, Dr. Conor Walsh, and Dr. Sabrina Paganoni.

8 Feb 2022

Researchers develop 3D human spinal cord implants for treating paralyzed patients

For the first time in the world, researchers from Sagol Center for Regenerative Biotechnology at Tel Aviv University have engineered 3D human spinal cord tissues and implanted them in lab model with long-term chronic paralysis.

7 Feb 2022

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

The Centers for Disease Control and Prevention estimate that someone in the United States has a stroke every 40 seconds.

4 Feb 2022

Majority of stroke patients experience permanent cognitive impairment

Paralysis and difficulty speaking are well-known problems following a stroke. Established treatment options are available for these problems.

4 Feb 2022

Researchers identify how a critical schistosomiasis drug works on the molecular level

Independent teams from Texas Biomedical Research Institute and the Medical College of Wisconsin have published two papers in Science Translational Medicine identifying how the only approved drug to treat schistosomiasis, a widespread parasitic worm infection, works on the molecular level.

6 Jan 2022

Research may pave the way for designing new therapies to combat schistosomiasis

Neglected tropical diseases (NTDs) represent a group of about 20 conditions that affect more than a billion people worldwide.

6 Jan 2022

Study analyzes the role of circular RNA in ALS pathology

Amyotrophic lateral sclerosis, known as ALS, is a neurodegenerative disorder which affects motor neurons. These are the neuronal cells responsible for muscle innervation, whose degenerations leads to progressive paralysis culminating with motor and respiratory failure.

21 Dec 2021

Researchers use machine learning to shed light on genetic mutations linked with spina bifida

Weill Cornell Medicine researchers are using machine learning, a form of artificial intelligence, to shed light on genetic mutations associated with spina bifida.

20 Dec 2021

Cannabinoid medicines have enormous therapeutic potential but reliable studies still lacking

For more than twenty years now, international research into the endocannabinoid system in the human body has been seeking to understand the mode of action of cannabis and its constituents.

18 Dec 2021

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

A new study suggests that low GBS incidence in vaccinated patients compared to non-vaccinated people should encourage the active propagation of vaccination against SARS-CoV-2.

15 Dec 2021

‘Moving molecule’ therapy for severe spinal cord injury

In this interview, News-Medical speaks to Dr. Stupp about his recent research into a therapy involving dancing molecules for the treatment of severe spinal cord injury.

7 Dec 2021

Novel anti-inflammatory drug target identified by CRISPR

In this interview, News-Medical speaks to Dr. Jeffrey Rathmell about his recent research into how metabolic pathways impact immune function.

1 Dec 2021

Tighter blood pressure management may lead to better spinal cord injury recovery

Patients with new spinal cord injuries whose blood pressure is maintained within a newly defined range during surgery may stand a better chance of regaining some mobility and functionality – even in patients with the most devastating injuries – according to a new study by researchers at UC San Francisco.

16 Nov 2021

Paralysis News and Research

Further Reading

Winners of the first CERF Medical Engineering Prize for ALS Research announced

Researchers develop 3D human spinal cord implants for treating paralyzed patients

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

Majority of stroke patients experience permanent cognitive impairment

Researchers identify how a critical schistosomiasis drug works on the molecular level

Research may pave the way for designing new therapies to combat schistosomiasis

Study analyzes the role of circular RNA in ALS pathology

Researchers use machine learning to shed light on genetic mutations linked with spina bifida

Cannabinoid medicines have enormous therapeutic potential but reliable studies still lacking

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

‘Moving molecule’ therapy for severe spinal cord injury

Novel anti-inflammatory drug target identified by CRISPR

Tighter blood pressure management may lead to better spinal cord injury recovery

New therapy harnesses "dancing molecules" to reverse paralysis, repair tissue after spinal cord injuries

Identifying an important protein for motor coordination

Hiding face movements with a mask can affect our ability to socially interact with others

Scientists show how cold could alleviate multiple sclerosis symptoms

Phase 2 trial shows COVID-19 recombinant protein vaccine elicits promising immunogenicity responses

FDA-approved drug encourages sensory neurons to regrow after injury

Wiggling worms offer new clues into the potential impact of diet on Alzheimer's

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News